Thomas J. Lamb – Law Offices of Thomas J. Lamb, P.A.

Drug Injury Watch: Testosterone Injections Or Shots Such As Depo-Testosterone Might Have Higher Risks Of Heart Attacks, Strokes, And Deaths

Drug Injury Watch: Testosterone Injections Or Shots Such As Depo-Testosterone Might Have Higher Risks Of Heart Attacks, Strokes, And Deaths New Medical Research Suggests The Safety Of A Testosterone Drug Might Depend On Its…more
|

SUMMARY: Plavix (clopidogrel) and Effient (prasugrel) are important antiplatelet blood-thinning medicines used to prevent heart attacks, strokes, and other clot-related diseases.

Drug Injury Watch: Long-Term Combined Plavix - Effient Use May Be Associated With An Increased Overall Risk Of Non-Cardiovascular Death Compared To Shorter Therapy Period FDA Drug Safety Communication Issued In November 2014…more
|

Drug Injury Watch: With Zofran - Birth Defects Lawsuits Filed, How Will GlaxoSmithKline Update Its Drug Label To Comply With New FDA Rule Effective June 2015

Drug Injury Watch: With Zofran - Birth Defects Lawsuits Filed, How Will GlaxoSmithKline Update Its Drug Label To Comply With New FDA Rule Effective June 2015 New FDA Rule Requires Drug Company To Replace Current Simple…more
|

Drug Injury Watch: Attention Deficit Hyperactivity Disorder Drugs Concerta And Ritalin Get New Warnings For Rhabdomyolysis In US And Priapism In Canada

Drug Injury Watch: Attention Deficit Hyperactivity Disorder Drugs Concerta And Ritalin Get New Warnings For Rhabdomyolysis In US And Priapism In Canada Muscle-Wasting Side Effect "Rhabdo" Seems To Apply To Entire ADHD Class…more
|

Drug Injury Watch: Diabetes Drugs Kombiglyze And Onglyza: Heart Failure Side Effect Seems To Be Valid, And FDA Notes There Is A Possible Increased Risk Of All-Cause Mortality

Drug Injury Watch: Diabetes Drugs Kombiglyze And Onglyza: Heart Failure Side Effect Seems To Be Valid, And FDA Notes There Is A Possible Increased Risk Of All-Cause Mortality As Analysis Did Not Reveal Causes Of The Increase…more
|

Drug Injury Watch: A 2004 Medical Journal Article Indicated A Possible Link Between The "Morning Sickness" Drug Use Of Zofran And Hypospadias

Drug Injury Watch: A 2004 Medical Journal Article Indicated A Possible Link Between The "Morning Sickness" Drug Use Of Zofran And Hypospadias However, It Seems No Further Research About This Congenital Birth Defect Being…more
|

Drug Injury Watch: In Canada, ADHD Drugs Like Adderall, Concerta, And Ritalin Are Getting New Warnings About Suicide-Related Adverse Events

In Canada, ADHD Drugs Like Adderall, Concerta, And Ritalin Are Getting New Warnings About Suicide-Related Adverse Events Increased Warning About The Risk Of Suicidal Thoughts And Behaviors Being Added To Attention Deficit…more
|

Drug Injury Watch: Diabetes Drugs Bydureon And Victoza: Thyroid Cancer Label Change In March 2015 Comes Without Much Notice

Drug Injury Watch: Diabetes Drugs Bydureon And Victoza: Thyroid Cancer Label Change In March 2015 Comes Without Much Notice FDA Letters To AstraZeneca And Novo Nordisk Approve Addition Of Information About Increased Risk For…more
|

Drug Injury Watch: YAZ / Yasmin Litigation Update For March 2015: According To Bayer's 2014 Annual Report, "Additional lawsuits are anticipated."

Drug Injury Watch: YAZ / Yasmin Litigation Update For March 2015: According To Bayer's 2014 Annual Report, "Additional lawsuits are anticipated." Bayer Claims It Settled About 300 Of These Cases While Another 1300 Lawsuits…more
|

Drug Injury Watch: Cardiovascular Safety Issues For Onglyza And Kombiglyze Will Be Discussed At April 2015 FDA Advisory Committee Meeting

Drug Injury Watch: Cardiovascular Safety Issues For Onglyza And Kombiglyze Will Be Discussed At April 2015 FDA Advisory Committee Meeting These Two New AstraZeneca Diabetes Medications With Saxagliptin Are Part Of The…more
|

First 2015 Update On Fosamax Femur Fracture Litigation: Not Much New Information To Report Out

First 2015 Update On Fosamax Femur Fracture Litigation: Not Much New Information To Report Out With New Jersey State Court Fosamax Lawsuits Now Assigned To Judge Mayer, We Hope These Cases Get Back On…more
|

A New Case Of Progressive Multifocal Leukoencephalopathy (PML) In A Patient Using Gilenya Is Reported By Novartis In Canada

A New Case Of Progressive Multifocal Leukoencephalopathy (PML) In A Patient Using Gilenya Is Reported By Novartis In Canada Company Is Investigating This Gilenya - PML Case To See Whether Brain Disease Might Be A Side Effect…more
|

Drug Injury Watch: Various Drug Safety Issues Continue To Be Associated With Novartis Multiple Sclerosis (MS) Medication Gilenya

Drug Injury Watch: Various Drug Safety Issues Continue To Be Associated With Novartis Multiple Sclerosis (MS) Medication Gilenya ISMP QuarterWatch Report From 2014 States Adverse Events Reports Show That Gilenya Cardiac Risks…more
|

Drug Injury Watch: Zofran Associated With Birth Defects When Used During Pregnancy As An "Off-Label" Morning Sickness Treatment

Drug Injury Watch: Zofran Associated With Birth Defects When Used During Pregnancy As An "Off-Label" Morning Sickness Treatment Medical Researchers Find Increased Risk Of Heart Defects And Cleft Palates In Babies Born To…more
|

Drug Injury Watch: Viagra / Cialis / Levitra: Prostate Cancer Recurrence When Used After Radical Prostatectomy Surgery

Drug Injury Watch: Viagra / Cialis / Levitra: Prostate Cancer Recurrence When Used After Radical Prostatectomy Surgery Researchers Surprised By Their Finding As Earlier Medical Studies Suggested Anticancer Effect In…more
|
Showing 1-15 of 394 Results
|
View per page
Page: of 27
Contact

Lumina Station, Suite 225 1908 Eastwood Road
Wilmington, NC 28403, United States

  • (910) 256-2971
  • (910) 256-2972

Areas of Practice
  • Personal Injury
  • Products Liability
  • Professional Malpractice
  • Toxic Torts
This profile may constitute attorney advertising. Prior results do not guarantee a similar outcome. Any correspondence with this profile holder does not constitute a client/attorney relationship. Neither the content on this profile nor transmissions between you and the profile holder through this profile are intended to provide legal or other advice or to create an attorney-client relationship.

All the intelligence you need, in one easy email:

Great! Your first step to building an email digest of JD Supra authors and topics. Log in with LinkedIn so we can start sending your digest...

Sign up for your custom alerts now, using LinkedIn ›

* With LinkedIn, you don't need to create a separate login to manage your free JD Supra account, and we can make suggestions based on your needs and interests. We will not post anything on LinkedIn in your name.
×